GSK (GSK) to support manufacture of Novavax' (NVAX) COVID-19 vaccine Mar 29, 2021 04:03PM
GSK to support manufacture of Novavax' COVID-19 vaccine Mar 29, 2021 04:02PM
Novavax (NVAX) Says COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial Jan 28, 2021 04:07PM
Novavax (NVAX) Announces COVID-19 Vaccine Clinical Development Progress Nov 30, 2020 06:30AM
Pre-Open Stock Movers 08/17: (CVAC) (TCON) (GOLD) Higher; (SRNE) Lower (more...) Aug 17, 2020 09:30AM


Aug 17, 2020 06:16AM Novavax (NVAX) Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Aug 13, 2020 08:31AM Novavax (NVAX), SK bioscience Announce Collaboration for Novavax' COVID-19 Vaccine Candidate
Aug 13, 2020 08:30AM Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
Aug 13, 2020 08:30AM Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
Jun 24, 2020 07:07PM Exclusive: Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines
Mar 12, 2020 09:32AM Pre-Open Movers 03/12: (CEMI) (INO) (APT) Higher; (ZAGG) (NCLH) (CCL) Lower (more...)
Aug 12, 2019 07:06AM Novavax (NVAX) Highlights New Data from Novavax Phase 3 Prepare Trial of ResVax at 2019 IDSOG Meetings
Jun 10, 2019 07:09AM Novavax (NVAX) Provides Updates on Global Pathways to Licensure for ResVax
Apr 9, 2019 04:19PM Novavax (NVAX) to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD
Feb 28, 2019 07:01AM Novavax (NVAX) Phase 3 Prepare Trial of ResVax for Prevention of RSV Disease in Infants Doesn't Meet Primary Endpoint
Apr 2, 2018 09:00AM Novavax to Present Clinical Data on RSV F and NanoFlu(TM) Vaccines at World Vaccine Congress
Apr 2, 2018 09:00AM Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress
Apr 2, 2018 09:00AM Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress
Mar 14, 2018 04:19PM Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
Mar 14, 2018 04:08PM Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
Mar 14, 2018 04:08PM Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
Dec 18, 2017 04:56PM Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu(TM) Vaccine
Dec 18, 2017 04:34PM Novavax (NVAX) Says Phase 3 Trial of RSV F Vaccine for Infants via Maternal Immunization Will Continue; Provides Update on Phase 1/2 Trial of NanoFlu Vaccine
Dec 18, 2017 04:32PM Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine
Dec 18, 2017 04:32PM Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine
Nov 7, 2017 04:05PM Novavax Reports Third Quarter 2017 Financial Results
Aug 8, 2017 04:05PM Novavax Reports Second Quarter 2017 Financial Results
Jul 24, 2017 04:07PM Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward
Jul 24, 2017 04:05PM Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
Nov 9, 2016 04:07PM Novavax (NVAX) Tops Q3 EPS by 2c; Will Implement Restructuring Plan
Dec 3, 2015 04:08PM Novavax (NVAX) Commences Enrollment in RSV F Vaccine Phase 3
Sep 29, 2015 06:51AM Novavax (NVAX) Announces Positive Top-Line Data from RSV F Vaccine Phase 2 in Infants
Sep 29, 2015 06:48AM Novavax (NVAX) Announces Receipt of Grant from Bill & Melinda Gates Foundation for RSV F Vaccine Phase 3